Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
11,094 total articles
Microsoft (MSFT) is trading at a valuation not seen since 2018 while its core cash machines - Azure, Office 365, and intelligent cloud services - continue to expand. This trade idea recommends a long entry with a clear stop and two-tiered targets, sized for a medium-risk, long-term recovery driven by renewed growth beats and margin leverage.
Amazon's scale across e-commerce, advertising, subscriptions and AWS still supports durable cash generation and a reasonable multiple. Recent weakness has pulled the stock toward its 52-week low range even as fundamentals (ROE ~20.5%, market cap ~$2.5T) remain intact. This is an actionable buy with a clear entry at $233.13, a stop at $216, and a lo…
EPAM trades near $77 after a brutal re-rating tied to a large customer ramp-down disclosure and class-action noise. Fundamentals still show healthy cash generation ($543.6M FCF), low leverage (debt/equity 0.05) and an attractive valuation (EV/EBITDA ~4.7). This trade idea argues the market has overshot on headline risk and that a measured long with…
Madison Air Solutions (MAIR) supplies mission-critical HVAC and thermal management systems to commercial environments including AI data centers, while also selling premium residential products. The company is profitable, has a multibillion-dollar revenue base, expanding backlog and attractive margins. We initiate a tactical long with a defined entr…
Air Canada looks like the most deeply discounted name among major carriers. Operational momentum, fleet optimization and a leaner balance sheet argue for upside. This trade plan targets a meaningful re-rating while limiting downside with a defined stop.
Scorpio Tankers (STNG) looks buyable here. Elevated Time Charter Equivalent (TCE) rates, a string of asset sales and long-term charters, and recent convertible-note issuances tied to targeted share repurchases give the company both cash and a visible path to accelerate capital returns. The stock trades at a modest P/E of 7.5 and a PB of ~1.22 with …
Qualcomm's $10B push into AI servers plus a $20B buyback and a healthy cash flow profile make it a compelling tactical long. At ~$222, the stock prices in a lot of mobile strength but not the full enterprise AI upside. This trade targets a return to the prior range near $260 if Dragonfly adoption and Tenstorrent integration show early traction, wit…
MoonLake Immunotherapeutics has materially de‑risked its lead program after FDA confirmations and positive Week 40 Phase 3 data. With cash runway into late 2027 and an upcoming BLA submission in H2 2026, the stock looks positioned for a re-rating if 52‑week data and regulatory engagement continue to favor approval. We outline a long trade with entr…
Novo Nordisk ($NVO) has been hammered to the mid-$40s after a year of pricing and competitive concerns. The selloff has pushed the stock to a single-digit P/E near 10x and a market cap of about $204 billion. Management is buying shares back and core obesity/diabetes demand remains sizable. This trade idea proposes a buy at $46.50, with a $42.00 sto…
Whitbread will likely unlock material cash by selectively disposing of parts of its estate. If management executes disciplined estate recycling, proceeds can fund buybacks, debt paydown and reinvestment, supporting a mid-single-digit multiple re-rate. We initiate a tactical long aiming for ~15% annualized return, with defined entry, stop and target…
Micron enters earnings riding an AI-driven demand wave and fresh Anthropic ties. Fundamentals are strong - $1.37T market cap, $10.3B free cash flow, and ROE north of 33% - yet the stock sits near its 52-week high with stretched momentum. This trade idea sells into the next 10 trading days anticipating a post-earnings pullback even if results top ex…
Ondas agreed to acquire Cyberhawk for about $125 million, bringing $45M+ of expected revenue (95% recurring) and a $95M backlog. The market barely moved. Fundamentals and cash per share cushion the risk; valuation is rich but a deal-driven re-rating plus defense tailwinds create a defined risk-reward swing trade.
Moderna is staging a comeback after a strong run this year. With an FDA decision on its mRNA influenza candidate due 08/05/2026, solid clinical progress across multiple programs, $7.5B in cash and improving technicals, the stock looks set for another leg higher. This trade idea lays out an actionable swing entry, stop and target with rationale and …
Cadence Design Systems is trading at premium multiples - P/E ~90, P/FCF ~75 - but the company generates strong free cash flow, has a healthy balance sheet and sits at the center of AI-driven semiconductor design workflows. This trade idea takes a constructive, risk-managed long view: enter on modest weakness, stop below structural support, target r…
Micron's core memory business sits squarely in the bottleneck layer of the AI infrastructure buildout. With a $1.36T market cap, double-digit ROE, and a multi-year supply agreement with Anthropic, the stock can re-rate to $1,600 after a strong report on 06/24/2026. This trade plan gives a concrete entry, stop and target, with clear horizon and risk…
Meren Energy (MREN) is trading at deeply depressed levels after a year of sector-wide weakness. The company appears to offer an asymmetric risk-reward: a defined entry at $3.50, a protective stop at $2.80 and a first target at $6.00 as near-term catalysts and structural operational gains drive re-rating over the next 45 trading days.
Meta is turning generative and recommendation AI into measurable ad revenue gains faster than the market expects. With Q1-style ad growth already reported (33% ad growth cited), strong free cash flow ($48.25B), modest leverage (debt/equity ~0.24) and a sub-$1.5T market cap, Meta looks attractive at current levels. This is a tactical long with a cle…
Applied Materials (AMAT) sits at the intersection of accelerating chip complexity and nascent AR/AI wearables optics. The stock is trading near its 52-week high, but fundamentals - including $5.34B in free cash flow, 35.6% ROE and a market cap of roughly $508B - support a patient long trade. We lay out an actionable plan with entry at $640.00, stop…
Micron sits at the center of the AI memory cycle. Strong fundamentals, cash generation, strategic partnerships and constrained supply make MU my biggest position today. This note lays out why I’m not selling, the valuation framing, catalysts to watch, and a concrete trade plan with entry, stop and target alongside explicit risks.
Achieve Life Sciences (ACHV) faces regulatory cadence around its cytisinicline NDA, but a recent financing, positive program readouts and a modest enterprise value leave upside if the company can fix any FDA deficiencies. This trade idea lays out an entry at $5.10, a $9.00 target and a $3.50 stop, with a long-term horizon tied to regulatory resolut…
Western Digital (WDC) is trading well below an investment-case ceiling that assumes sustained AI-driven storage demand. Fundamentals show accelerating revenue and margin improvement, healthy free cash flow, and light leverage; technical momentum is strong but overbought. This trade is a long-term position (180 trading days) that aims to capture fur…
Arxis (ARXS) is a newly public aerospace components maker that looks like a classic high-quality compounder: diversified electronic and mechanical product lines, scale in defense and space supply chains, and momentum in both price and volume. The stock trades at a premium valuation, but fundamentals and tight short interest create a favorable asymm…
Advanced Micro Devices is trading near $552 after a blistering run. The company’s product mix - CPUs, GPUs, accelerators and adaptive SoCs - plus a clean balance sheet and accelerating AI deployments make a case for further share gains in AI infrastructure. Valuation is steep, so this is a conviction long with disciplined risk controls: entry $551.…
NetEase is trading at a reasonable valuation today (PE 16.3, market cap ~$78.4B) while accelerating international initiatives and selective investments in AI and IP partnerships. We see scope for a re-rating to a mid-teens-higher PE as overseas revenue scales and recurring streams (subscriptions, Yanxuan, Cloud Music) deepen. Trade idea: buy NTES a…
MakeMyTrip (MMYT) has faced heavy selling after a short-seller report and travel softness, but the core business - India’s leading online travel agency - still generates strong unit economics, holds a manageable balance sheet, and benefits from structural travel growth. The risk-reward at the current $46 area favors a measured long trade. Trade pla…
